http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103263671-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6b9ed41ec71e1e3d004841f54c9eabd8 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 |
| filingDate | 2013-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24971cafe003b994fe91fce1ef158a0c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_017c2240a0c79832c9da23982fc7d649 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e48b24be868c333846cb571d0feee7e6 |
| publicationDate | 2015-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103263671-B |
| titleOfInvention | Preparation and application of anti-tumor activator nanostructure lipid carrier |
| abstract | The invention relates to a preparation and application of an anti-tumor activator nanostructure lipid carrier, and in particular relates to a 17-allylamino-17-demethoxygeldanamycin nanostructure lipid carrier which has the following formula: 50 to 500mg/L of medicament, 50 to 150g/L of nanostructure lipid carrier taking medium chain triglyceride as a liquid-phase lipid, 10 to 30g/L of surfactant and the balance of solvent for injection. |
| priorityDate | 2013-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 32.